Article
Reproducibility, performance, and clinical utility of a genetic risk prediction model for prostate cancer in Japanese.
PloS one - 1 Jan 2012
Akamatsu Shusuke, Takahashi Atsushi, Takata Ryo, Kubo Michiaki, Inoue Takahiro, Morizono Takashi, Tsunoda Tatsuhiko, Kamatani Naoyuki, Haiman Christopher A, Wan Peggy, Chen Gary K, Le Marchand Loic, Kolonel Laurence N, Henderson Brian E, Fujioka Tomoaki, Habuchi Tomonori, Nakamura Yusuke, Ogawa Osamu, Nakagawa Hidewaki
Abstract excerpt
Prostate specific antigen (PSA) is widely used as a diagnostic biomarker for prostate cancer (PC). However, due to its low predictive performance, many patients without PC suffer from the harms of unnecessary prostate needle biopsies. The present study aims to evaluate the reproducibility and performance of a genetic risk prediction model in Japanese and estimate its utility as a diagnostic biomarker in a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
